These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35664796)

  • 1. Anlotinib Downregulates RGC32 Which Provoked by Bevacizumab.
    Liu Z; Qin T; Yuan X; Yang J; Shi W; Zhang X; Jia Y; Liu S; Wang J; Li K
    Front Oncol; 2022; 12():875888. PubMed ID: 35664796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
    Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J
    Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling.
    Qin T; Liu Z; Wang J; Xia J; Liu S; Jia Y; Liu H; Li K
    Cancer Biol Med; 2020 Aug; 17(3):753-767. PubMed ID: 32944404
    [No Abstract]   [Full Text] [Related]  

  • 4. Overexpression of response gene to complement 32 (RGC32) promotes cell invasion and induces epithelial-mesenchymal transition in lung cancer cells via the NF-κB signaling pathway.
    Sun Q; Yao X; Ning Y; Zhang W; Zhou G; Dong Y
    Tumour Biol; 2013 Oct; 34(5):2995-3002. PubMed ID: 23715780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGC32 promotes the progression of ccRCC by activating the NF-κB/SHP2/EGFR signaling pathway.
    Zhang J; Sun Y; Tang K; Xu H; Xiao J; Li Y
    Aging (Albany NY); 2024 May; 16():. PubMed ID: 38809518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways
    Zhang X; Zhang Y; Jia Y; Qin T; Zhang C; Li Y; Huang C; Liu Z; Wang J; Li K
    Cancer Biol Med; 2020 May; 17(2):418-432. PubMed ID: 32587778
    [No Abstract]   [Full Text] [Related]  

  • 7. Anlotinib Suppresses Colorectal Cancer Proliferation and Angiogenesis via Inhibition of AKT/ERK Signaling Cascade.
    Yang Q; Ni L; Imani S; Xiang Z; Hai R; Ding R; Fu S; Wu JB; Wen Q
    Cancer Manag Res; 2020; 12():4937-4948. PubMed ID: 32606981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung Cancer Cell Through Suppressing the MEK/ERK Pathway.
    Hu H; Liu Y; Tan S; Xie XX; He J; Luo F; Wang L
    Cancer Manag Res; 2020; 12():3579-3587. PubMed ID: 32547195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma.
    Song F; Hu B; Cheng JW; Sun YF; Zhou KQ; Wang PX; Guo W; Zhou J; Fan J; Chen Z; Yang XR
    Cell Death Dis; 2020 Jul; 11(7):573. PubMed ID: 32709873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of response gene to complement 32 (RGC32) induces apoptosis and inhibits cell growth, migration, and invasion in human lung cancer cells.
    Xu R; Shang C; Zhao J; Han Y; Liu J; Chen K; Shi W
    Mol Cell Biochem; 2014 Sep; 394(1-2):109-18. PubMed ID: 24833469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
    Song YH; Zhang CQ; Chen FF; Lin XY
    Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway.
    Yuan M; Guo XL; Chen JH; He Y; Liu ZQ; Zhang HP; Ren J; Xu Q
    Neoplasma; 2022 Jul; 69(4):807-819. PubMed ID: 35471977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of DERL3 Affecting the Proliferation, Invasion and Metastasis of Lung Adenocarcinoma A549 Cells].
    Zhou D; Wang J; Yang K; Zhang L; Zheng Q; Bai J; Hu Y; Mu Q; Yin C; Li H
    Zhongguo Fei Ai Za Zhi; 2020 Aug; 23(8):638-645. PubMed ID: 32838486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anlotinib inhibits the proliferation, migration and invasion, and induces apoptosis of breast cancer cells by downregulating TFAP2C.
    Fang F; Yuan Q
    Oncol Lett; 2022 Feb; 23(2):46. PubMed ID: 34976158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells.
    Liang L; Hui K; Hu C; Wen Y; Yang S; Zhu P; Wang L; Xia Y; Qiao Y; Sun W; Fei J; Chen T; Zhao F; Yang B; Jiang X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):71. PubMed ID: 30755242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma.
    Xu J; Chen C; Sun K; Shi Q; Wang B; Huang Y; Ren T; Tang X
    Front Oncol; 2023; 13():1192472. PubMed ID: 37404767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CK2α Regulates the Metastases and Migration of Lung Adenocarcinoma 
A549 Cell Line through PI3K/Akt/GSK-3β Signal Pathway].
    Wu A; Li M; Mai Z; Li S; Yang Z
    Zhongguo Fei Ai Za Zhi; 2017 Apr; 20(4):233-238. PubMed ID: 28442011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anlotinib suppresses metastasis and multidrug resistance
    Yan LH; Zhang D; Mo SS; Yuan H; Mo XW; Zhao JM
    J Cancer; 2021; 12(7):2092-2104. PubMed ID: 33754008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic role of epithelial cell transforming sequence 2 in lung adenocarcinoma cells.
    Tan H; Wang X; Yang X; Li H; Liu B; Pan P
    Exp Ther Med; 2016 Oct; 12(4):2088-2094. PubMed ID: 27698697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent use of anlotinib overcomes acquired resistance to EGFR-TKI in patients with advanced EGFR-mutant non-small cell lung cancer.
    Zhang C; Cao H; Cui Y; Jin S; Gao W; Huang C; Guo R
    Thorac Cancer; 2021 Oct; 12(19):2574-2584. PubMed ID: 34510760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.